Literature DB >> 35254426

A new mass spectral library for high-coverage and reproducible analysis of the Plasmodium falciparum-infected red blood cell proteome.

Ghizal Siddiqui1, Amanda De Paoli1, Christopher A MacRaild1, Anna E Sexton1, Coralie Boulet2, Anup D Shah3,4, Mitchell B Batty1, Ralf B Schittenhelm3, Teresa G Carvalho2, Darren J Creek1.   

Abstract

BACKGROUND: Plasmodium falciparum causes the majority of malaria mortality worldwide, and the disease occurs during the asexual red blood cell (RBC) stage of infection. In the absence of an effective and available vaccine, and with increasing drug resistance, asexual RBC stage parasites are an important research focus. In recent years, mass spectrometry-based proteomics using data-dependent acquisition has been extensively used to understand the biochemical processes within the parasite. However, data-dependent acquisition is problematic for the detection of low-abundance proteins and proteome coverage and has poor run-to-run reproducibility.
RESULTS: Here, we present a comprehensive P. falciparum-infected RBC (iRBC) spectral library to measure the abundance of 44,449 peptides from 3,113 P. falciparum and 1,617 RBC proteins using a data-independent acquisition mass spectrometric approach. The spectral library includes proteins expressed in the 3 morphologically distinct RBC stages (ring, trophozoite, schizont), the RBC compartment of trophozoite-iRBCs, and the cytosolic fraction from uninfected RBCs. This spectral library contains 87% of all P. falciparum proteins that have previously been reported with protein-level evidence in blood stages, as well as 692 previously unidentified proteins. The P. falciparum spectral library was successfully applied to generate semi-quantitative proteomics datasets that characterize the 3 distinct asexual parasite stages in RBCs, and compared artemisinin-resistant (Cam3.IIR539T) and artemisinin-sensitive (Cam3.IIrev) parasites.
CONCLUSION: A reproducible, high-coverage proteomics spectral library and analysis method has been generated for investigating sets of proteins expressed in the iRBC stage of P. falciparum malaria. This will provide a foundation for an improved understanding of parasite biology, pathogenesis, drug mechanisms, and vaccine candidate discovery for malaria.
© The Author(s) 2022. Published by Oxford University Press GigaScience.

Entities:  

Keywords:  LC-MS/MS; Plasmodium falciparum; data-dependent acquisition; data-independent acquisition; malaria; proteomics; red blood cells

Mesh:

Substances:

Year:  2022        PMID: 35254426      PMCID: PMC8900498          DOI: 10.1093/gigascience/giac008

Source DB:  PubMed          Journal:  Gigascience        ISSN: 2047-217X            Impact factor:   6.524


  65 in total

1.  Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics.

Authors:  Juri Rappsilber; Yasushi Ishihama; Matthias Mann
Journal:  Anal Chem       Date:  2003-02-01       Impact factor: 6.986

2.  A model for random sampling and estimation of relative protein abundance in shotgun proteomics.

Authors:  Hongbin Liu; Rovshan G Sadygov; John R Yates
Journal:  Anal Chem       Date:  2004-07-15       Impact factor: 6.986

3.  Profiling the human hippocampal proteome at all pathologic stages of Alzheimer's disease.

Authors:  David C Hondius; Pim van Nierop; Ka Wan Li; Jeroen J M Hoozemans; Roel C van der Schors; Elise S van Haastert; Saskia M van der Vies; Annemieke J M Rozemuller; August B Smit
Journal:  Alzheimers Dement       Date:  2016-01-06       Impact factor: 21.566

4.  Multi-omic Characterization of the Mode of Action of a Potent New Antimalarial Compound, JPC-3210, Against Plasmodium falciparum.

Authors:  Geoffrey W Birrell; Matthew P Challis; Amanda De Paoli; Dovile Anderson; Shane M Devine; Gavin D Heffernan; David P Jacobus; Michael D Edstein; Ghizal Siddiqui; Darren J Creek
Journal:  Mol Cell Proteomics       Date:  2019-12-13       Impact factor: 5.911

5.  Multi-omics Based Identification of Specific Biochemical Changes Associated With PfKelch13-Mutant Artemisinin-Resistant Plasmodium falciparum.

Authors:  Ghizal Siddiqui; Anubhav Srivastava; Adrian S Russell; Darren J Creek
Journal:  J Infect Dis       Date:  2017-05-01       Impact factor: 5.226

6.  Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates.

Authors:  Judith Straimer; Nina F Gnädig; Benoit Witkowski; Chanaki Amaratunga; Valentine Duru; Arba Pramundita Ramadani; Mélanie Dacheux; Nimol Khim; Lei Zhang; Stephen Lam; Philip D Gregory; Fyodor D Urnov; Odile Mercereau-Puijalon; Françoise Benoit-Vical; Rick M Fairhurst; Didier Ménard; David A Fidock
Journal:  Science       Date:  2014-12-11       Impact factor: 47.728

7.  Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae.

Authors:  Timothy J Griffin; Steven P Gygi; Trey Ideker; Beate Rist; Jimmy Eng; Leroy Hood; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2002-04       Impact factor: 5.911

8.  Insights into the intracellular localization, protein associations and artemisinin resistance properties of Plasmodium falciparum K13.

Authors:  Nina F Gnädig; Barbara H Stokes; Rachel L Edwards; Gavreel F Kalantarov; Kim C Heimsch; Michal Kuderjavy; Audrey Crane; Marcus C S Lee; Judith Straimer; Katja Becker; Ilya N Trakht; Audrey R Odom John; Sachel Mok; David A Fidock
Journal:  PLoS Pathog       Date:  2020-04-20       Impact factor: 6.823

9.  System-wide biochemical analysis reveals ozonide antimalarials initially act by disrupting Plasmodium falciparum haemoglobin digestion.

Authors:  Carlo Giannangelo; Ghizal Siddiqui; Amanda De Paoli; Bethany M Anderson; Laura E Edgington-Mitchell; Susan A Charman; Darren J Creek
Journal:  PLoS Pathog       Date:  2020-06-26       Impact factor: 6.823

10.  Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda.

Authors:  Aline Uwimana; Eric Legrand; Barbara H Stokes; Jean-Louis Mangala Ndikumana; Marian Warsame; Noella Umulisa; Daniel Ngamije; Tharcisse Munyaneza; Jean-Baptiste Mazarati; Kaendi Munguti; Pascal Campagne; Alexis Criscuolo; Frédéric Ariey; Monique Murindahabi; Pascal Ringwald; David A Fidock; Aimable Mbituyumuremyi; Didier Menard
Journal:  Nat Med       Date:  2020-08-03       Impact factor: 53.440

View more
  3 in total

1.  A new mass spectral library for high-coverage and reproducible analysis of the Plasmodium falciparum-infected red blood cell proteome.

Authors:  Ghizal Siddiqui; Amanda De Paoli; Christopher A MacRaild; Anna E Sexton; Coralie Boulet; Anup D Shah; Mitchell B Batty; Ralf B Schittenhelm; Teresa G Carvalho; Darren J Creek
Journal:  Gigascience       Date:  2022-03-07       Impact factor: 6.524

2.  Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway.

Authors:  Rebecca C S Edgar; Ghizal Siddiqui; Katheryn Hjerrild; Tess R Malcolm; Natalie B Vinh; Chaille T Webb; Clare Holmes; Christopher A MacRaild; Hope C Chernih; Willy W Suen; Natalie A Counihan; Darren J Creek; Peter J Scammells; Sheena McGowan; Tania F de Koning-Ward
Journal:  Elife       Date:  2022-09-13       Impact factor: 8.713

3.  Red Blood Cell BCL-xL Is Required for Plasmodium falciparum Survival: Insights into Host-Directed Malaria Therapies.

Authors:  Coralie Boulet; Ghizal Siddiqui; Taylah L Gaynor; Christian Doerig; Darren J Creek; Teresa G Carvalho
Journal:  Microorganisms       Date:  2022-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.